Skip to main content
U.S. flag

An official website of the United States government

Join NIA at AAIC 2022 for the latest in dementia research!

Eliezer Masliah
Eliezer MASLIAH,
Division of Neuroscience (DN)

Chill out from this season’s hot weather with the coolest dementia science of the summer that will be presented and discussed later this month at the annual Alzheimer’s Association International Conference (AAIC)! This year, the event will be hybrid, held both online and in San Diego, July 31–August 4, with some earlier-in-July preconference sessions. My NIA colleagues and I hope you’re as excited as we are to connect in person and virtually.

Don’t miss these events!

As always, NIA leadership and staff will participate in several AAIC sessions. Our presentations provide an excellent opportunity to learn more about NIA and broader NIH Alzheimer’s disease and related dementias scientific initiatives and tips on applying for funding to support your research. Be sure to add these key NIA preconference sessions to your calendars: 

NIA-AA Symposium: Enabling Precision Medicine for Alzheimer’s Disease Through Open Science

Thursday, July 28
1–6 p.m. Pacific Time (PT)

Friday, July 29
8 a.m.–6 p.m. PT

The fifth annual edition of this symposium will highlight NIA-supported translational research programs to better understand the complex mechanisms of Alzheimer’s disease and related dementias, identify new drug targets and biomarkers, and develop innovative animal models.

NIA-AA Symposium: IMPACT Embedded Pragmatic Clinical Trials

Friday, July 29
10 a.m.–4:30 p.m. PT

This symposium will train investigators in the design and conduct of embedded pragmatic clinical trials to improve care for persons living with dementia, and their care partners.

Look for NIA poster presentations

NIA staff will present scientific posters throughout the AAIC event, with topics of note including:

  • Alzheimer’s Disease Preclinical Efficacy Database (AlzPED): Optimizing the scientific rigor and reproducibility of preclinical research in Alzheimer’s disease
  • Examining the level of test burden in NIA’s Alzheimer’s disease and related dementias clinical trials
  • Increasing awareness and interest in Alzheimer’s disease and related dementias clinical trials using culturally tailored messages: A synthesis of three national surveys, 2019–2021
  • Improving Asian Americans’ awareness and interest in clinical research: Examining the role of culturally tailored messaging

NIA grantees in the spotlight

Researchers leading NIA-funded projects are among the AAIC plenary speakers. Key topics will include new results from the EXERT Trial, perspectives from a South American country on biomarkers in Alzheimer’s disease clinical trials, plasma biomarkers of brain amyloid-beta and tau pathologies in Down syndrome, and next-generation Alzheimer’s therapeutics.

Because other details were still unfolding as of the time of this blog post, be sure to follow NIA on Twitter for our latest information. If you’re planning to attend AAIC either in person or virtually, register today and track #AAIC22 for updates.

We look forward to catching up with you at AAIC 2022!

Add new comment

Your e-mail address will not be posted.

Plain text

  • Allowed HTML tags: <p> <br>
  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

An official website of the National Institutes of Health